The Preeclampsia - the leading cause of maternal and neonatal mortality in the world - review of literature
DOI:
https://doi.org/10.12775/QS.2024.17.53388Keywords
preeclampsia, PIGF, placenta, opthalmic artery dopppler, aspirinAbstract
Background: This review analyzes current knowledge on the pathophysiology, prevention and art of treatment of preeclampsia. Preeclampsia (known as EPH-gestosis) is nowadays the leading cause of maternal and neonatal mortality in the world. According to statistics it affects up to 5% of pregnant women. The symptoms are high blood pressure, edema, proteinuria. The scientists all over the world are trying their best to know the pathogenesis to devise a cure for the disease.
Aim of study: The goal of this article was to gather information about the pathophisiology and treatment of preeclempsia to prevent the risk of ilness’ development.
Materials and methods: A review of the literature available in the “PubMed”, Google Scholar and Medline databases. The search was performed by using following keywords: “preeclampsia”, “ophthalmic artery doppler”, “PIGF”, “aspirin”, “placenta”.
Results and conclusions: In spite of the progress of science the preeclampsia is still a serious threat for pregnant women all around the world. Thank to the advanced molecular and ultrasonographic techniques the doctors can estimate the risk of complications. The most important is screening, which helps the doctors to define the group of risk and then launch the treatment. That should decrease the amount of maternal and neonatal complications and deaths.
References
Sibai BM, Stella CL. Diagnosis and management of atypical preeclampsia-eclampsia. Am J Obstet Gynecol. 2009;200(5):481.e1-481.e7.
Chames MC, Livingston JC, Ivester TS, Barton JR, Sibai BM. Late postpartum eclampsia: A preventable disease? In: American Journal of Obstetrics and Gynecology. Mosby Inc.; 2002. p. 1174–7.
Hauspurg A, Jeyabalan A. Postpartum preeclampsia or eclampsia: defining its place and management among the hypertensive disorders of pregnancy. Vol. 226, American Journal of Obstetrics and Gynecology. Elsevier Inc.; 2022. p. S1211–21.
Phipps EA, Thadhani R, Benzing T, Ananth Karumanchi S. Pre-eclampsia: pathogenesis, novel diagnostics and therapies HHS Public Access. Nat Rev Nephrol. 2019;15(5):275–89.
Wang Y, Li B, Zhao Y. Inflammation in Preeclampsia: Genetic Biomarkers, Mechanisms, and Therapeutic Strategies. Front Immunol. 2022 Jul 8;13.
Sakowicz A, Bralewska M, Rybak-Krzyszkowska M, Grzesiak M, Pietrucha T. New Ideas for the Prevention and Treatment of Preeclampsia and Their Molecular Inspirations. Vol. 24, International Journal of Molecular Sciences. Multidisciplinary Digital Publishing Institute (MDPI); 2023.
Tenório MB, Ferreira RC, Moura FA, Bueno NB, Menezes De Oliveira AC, Oliveira M, et al. Cross-Talk between Oxidative Stress and Inflammation in Preeclampsia. 2019.
Rana S, Lemoine E, Granger J, Karumanchi SA. Preeclampsia: Pathophysiology, Challenges, and Perspectives. Circ Res. 2019 Mar 29;124(7):1094–112.
Gray KJ, Saxena R, Karumanchi SA. Genetic predisposition to preeclampsia is conferred by fetal DNA variants near FLT1, a gene involved in the regulation of angiogenesis. Am J Obstet Gynecol. 2018 Feb 1;218(2):211–8.
Tomimatsu T, Mimura K, Matsuzaki S, Endo M, Kumasawa K, Kimura T. Preeclampsia: Maternal systemic vascular disorder caused by generalized endothelial dysfunction due to placental antiangiogenic factors. Vol. 20, International Journal of Molecular Sciences. MDPI AG; 2019.
Kalafat E, Thilaganathan B. Cardiovascular origins of preeclampsia. Vol. 29, Current Opinion in Obstetrics and Gynecology. Lippincott Williams and Wilkins; 2017. p. 383–9.
Nicolaides KH, Sarno M, Wright A. Ophthalmic artery Doppler in the prediction of preeclampsia. Vol. 226, American Journal of Obstetrics and Gynecology. Elsevier Inc.; 2022. p. S1098–101.
Hata T, Hata K, Moritake K, Izumo J. Maternal ophthalmic artery Doppler velocimetry in normotensive pregnancies and pregnancies complicated hypertensive disorders. 1997.
Bokuda K, Ichihara A. Preeclampsia up to date—What’s going on? Vol. 46, Hypertension Research. Springer Nature; 2023. p. 1900–7.
McCoy S, Baldwin K. Pharmacotherapeutic options for the treatment of preeclampsia. Vol. 66, American Journal of Health-System Pharmacy. American Society of Health-Systems Pharmacy; 2009. p. 337–44.
Rolnik DL, Nicolaides KH, Poon LC. Prevention of preeclampsia with aspirin. Vol. 226, American Journal of Obstetrics and Gynecology. Elsevier Inc.; 2022. p. S1108–19.
Atallah A, Lecarpentier E, Goffinet F, Doret-Dion M, Gaucherand P, Tsatsaris V. Aspirin for Prevention of Preeclampsia. Drugs. 2017 Nov 1;77(17):1819–31.
Chen WC, Lin KH, Huang YT, Tsai TJ, Sun WC, Chuah SK, et al. The risk of lower gastrointestinal bleeding in low-dose aspirin users. Aliment Pharmacol Ther. 2017 Jun 1;45(12):1542–50.
Leonhardt A, Bernert S, Watzer B, Schmitz-Ziegler G, Rg H, Seyberth W. Low-Dose Aspirin in Pregnancy: Maternal and Neonatal Aspirin Concentrations and Neonatal Prostanoid Formation [Internet]. 2003. Available from: http://www.pediatrics.org/cgi/content/full/111/1/e77
Wyatt-Ashmead J. Antenatal closure of the ductus arteriosus and hydrops fetalis. Pediatric and Developmental Pathology. 2011;14(6):469–74.
Wertaschnigg D, Reddy M, Mol BWJ, Da Silva Costa F, Rolnik DL. Evidence-Based Prevention of Preeclampsia: Commonly Asked Questions in Clinical Practice. Vol. 2019, Journal of Pregnancy. Hindawi Limited; 2019.
Ramos JGL, Sass N, Costa SHM. Pré-eclâmpsia. Vol. 39, Revista Brasileira de Ginecologia e Obstetricia. Federacao Brasileira das Sociedades de Ginecologia e Obstetricia; 2017. p. 496–512.
Tasatargil A, Ogutman C, Golbasi I, Karasu E, Dalaklioglu S. Comparison of the Vasodilatory Effect of Nadroparin, Enoxaparin, Dalteparin, and Unfractioned Heparin in Human Internal Mammary Artery [Internet]. Available from: http://journals.lww.com/cardiovascularpharm
McLaughlin K, Baczyk D, Potts A, Hladunewich M, Parker JD, Kingdom JCP. Low Molecular Weight Heparin Improves Endothelial Function in Pregnant Women at High Risk of Preeclampsia. Vol. 69, Hypertension. Lippincott Williams and Wilkins; 2017. p. 180–8.
Phipps E, Prasanna D, Brima W, Jim B. Preeclampsia: Updates in pathogenesis, definitions, and guidelines. Vol. 11, Clinical Journal of the American Society of Nephrology. American Society of Nephrology; 2016. p. 1102–13.
Frank Wolf M, Peleg D, Kariv Silberstein N, Assy N, Djibre A, Ben-Shachar I. Correlation between changes in liver stiffness and preeclampsia as shown by transient elastography. Hypertens Pregnancy. 2016 Oct 1;35(4):536–41.
Natarajan SK, Thangaraj KR, Eapen CE, Ramachandran A, Mukhopadhya A, Mathai M, et al. Liver injury in acute fatty liver of pregnancy: Possible link to placental mitochondrial dysfunction and oxidative stress. Hepatology. 2010 Jan;51(1):191–200.
Alese MO, Moodley J, Naicker T. Preeclampsia and HELLP syndrome, the role of the liver. Vol. 34, Journal of Maternal-Fetal and Neonatal Medicine. Taylor and Francis Ltd.; 2021. p. 117–23.
Witlin AG, Saade G IL, Mattar F, Sibai BM, Galveston Md. Predictors of neonatal outcome in women with severe preeclampsia or eclampsia between 24 and 33 weeks’ gestation.
van Esch JJA, van Heijst AF, de Haan AFJ, van der Heijden OWH. Early-onset preeclampsia is associated with perinatal mortality and severe neonatal morbidity. Journal of Maternal-Fetal and Neonatal Medicine. 2017 Dec 2;30(23):2789–94.
Werner EF, Han CS, Savitz DA, Goldshore M, Lipkind HS. Health outcomes for vaginal compared with cesarean delivery of appropriately grown preterm neonates. In: Obstetrics and Gynecology. Lippincott Williams and Wilkins; 2013. p. 1195–200.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Paweł Staszczak, Gabriela Różańska-Smuszkiewicz, Paweł Smuszkiewicz-Różański, Barbara Jaworska, Weronika Kmiotek, Radosław Oronowicz, Dagmara Ragan, Aldona Pażyra, Natalia Kusak, Natalia Żak, Paweł Stanicki
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 166
Number of citations: 0
